R306465

· Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for R306465, covering 2010-04-27 to 2010-04-27. Get the full timeline:

Most recent: Clinical Trial Update: A Research Study to Evaluate the Safety of R306465, a Drug in Development for Cancer and to Study the Absorption, Break Down and Elimination in Patients With Advanced Solid Malignancies. [Phase 1]

See pricing